212 related articles for article (PubMed ID: 19664212)
21. [In vitro effect of alendronate on chondrocytes and articular cartilage and subchondral bone in rabbit anterior cruciate ligament transection model].
Hu H; Zhang L; Li B; Zhang Y; Liu X; Tian F; Cheng T; Wang Z
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2009 Dec; 23(12):1474-81. PubMed ID: 20073314
[TBL] [Abstract][Full Text] [Related]
22. Production of the chemokine RANTES by articular chondrocytes and role in cartilage degradation.
Alaaeddine N; Olee T; Hashimoto S; Creighton-Achermann L; Lotz M
Arthritis Rheum; 2001 Jul; 44(7):1633-43. PubMed ID: 11465714
[TBL] [Abstract][Full Text] [Related]
23. Beneficial effect of a sturgeon-based bioactive compound on gene expression of tumor necrosis factor-alpha, matrix metalloproteinases and type-10 collagen in human chondrocytes.
Catanzaro R; Marotta F; Jain S; Rastmanesh R; Allegri F; Celep G; Lorenzetti A; Polimeni A; Yadav H
J Biol Regul Homeost Agents; 2012; 26(3):337-45. PubMed ID: 23034253
[TBL] [Abstract][Full Text] [Related]
24. Aggravation of ADAMTS and matrix metalloproteinase production and role of ERK1/2 pathway in the interaction of osteoarthritic subchondral bone osteoblasts and articular cartilage chondrocytes -- possible pathogenic role in osteoarthritis.
Prasadam I; Crawford R; Xiao Y
J Rheumatol; 2012 Mar; 39(3):621-34. PubMed ID: 22247346
[TBL] [Abstract][Full Text] [Related]
25. Vitexin alleviates interleukin-1β-induced inflammatory responses in chondrocytes from osteoarthritis patients: Involvement of HIF-1α pathway.
Yang H; Huang J; Mao Y; Wang L; Li R; Ha C
Scand J Immunol; 2019 Aug; 90(2):e12773. PubMed ID: 31055848
[TBL] [Abstract][Full Text] [Related]
26. Elevated expression of periostin in human osteoarthritic cartilage and its potential role in matrix degradation via matrix metalloproteinase-13.
Attur M; Yang Q; Shimada K; Tachida Y; Nagase H; Mignatti P; Statman L; Palmer G; Kirsch T; Beier F; Abramson SB
FASEB J; 2015 Oct; 29(10):4107-21. PubMed ID: 26092928
[TBL] [Abstract][Full Text] [Related]
27. Cannabinoid WIN-55,212-2 mesylate inhibits interleukin-1β induced matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase expression in human chondrocytes.
Dunn SL; Wilkinson JM; Crawford A; Le Maitre CL; Bunning RA
Osteoarthritis Cartilage; 2014 Jan; 22(1):133-44. PubMed ID: 24211233
[TBL] [Abstract][Full Text] [Related]
28. Osteoblasts from the sclerotic subchondral bone downregulate aggrecan but upregulate metalloproteinases expression by chondrocytes. This effect is mimicked by interleukin-6, -1beta and oncostatin M pre-treated non-sclerotic osteoblasts.
Sanchez C; Deberg MA; Piccardi N; Msika P; Reginster JY; Henrotin YE
Osteoarthritis Cartilage; 2005 Nov; 13(11):979-87. PubMed ID: 16243232
[TBL] [Abstract][Full Text] [Related]
29. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes.
Tetlow LC; Adlam DJ; Woolley DE
Arthritis Rheum; 2001 Mar; 44(3):585-94. PubMed ID: 11263773
[TBL] [Abstract][Full Text] [Related]
30. Activation of matrix metalloproteinases 2, 9, and 13 by activated protein C in human osteoarthritic cartilage chondrocytes.
Jackson MT; Moradi B; Smith MM; Jackson CJ; Little CB
Arthritis Rheumatol; 2014 Jun; 66(6):1525-36. PubMed ID: 24574263
[TBL] [Abstract][Full Text] [Related]
31. Mechanotransduction via integrins and interleukin-4 results in altered aggrecan and matrix metalloproteinase 3 gene expression in normal, but not osteoarthritic, human articular chondrocytes.
Millward-Sadler SJ; Wright MO; Davies LW; Nuki G; Salter DM
Arthritis Rheum; 2000 Sep; 43(9):2091-9. PubMed ID: 11014361
[TBL] [Abstract][Full Text] [Related]
32. Vascular endothelial growth factor isoforms and their receptors are expressed in human osteoarthritic cartilage.
Enomoto H; Inoki I; Komiya K; Shiomi T; Ikeda E; Obata K; Matsumoto H; Toyama Y; Okada Y
Am J Pathol; 2003 Jan; 162(1):171-81. PubMed ID: 12507900
[TBL] [Abstract][Full Text] [Related]
33. Linked decreases in liver kinase B1 and AMP-activated protein kinase activity modulate matrix catabolic responses to biomechanical injury in chondrocytes.
Petursson F; Husa M; June R; Lotz M; Terkeltaub R; Liu-Bryan R
Arthritis Res Ther; 2013 Jul; 15(4):R77. PubMed ID: 23883619
[TBL] [Abstract][Full Text] [Related]
34. Prostaglandin E2 exerts catabolic effects in osteoarthritis cartilage: evidence for signaling via the EP4 receptor.
Attur M; Al-Mussawir HE; Patel J; Kitay A; Dave M; Palmer G; Pillinger MH; Abramson SB
J Immunol; 2008 Oct; 181(7):5082-8. PubMed ID: 18802112
[TBL] [Abstract][Full Text] [Related]
35. Estrogen receptor-related receptor α regulation by interleukin-1β in prostaglandin E(2)- and cAMP-dependent pathways in osteoarthritic chondrocytes.
Bonnelye E; Reboul P; Duval N; Cardelli M; Aubin JE
Arthritis Rheum; 2011 Aug; 63(8):2374-84. PubMed ID: 21506092
[TBL] [Abstract][Full Text] [Related]
36. Platelet-rich plasma releasate inhibits inflammatory processes in osteoarthritic chondrocytes.
van Buul GM; Koevoet WL; Kops N; Bos PK; Verhaar JA; Weinans H; Bernsen MR; van Osch GJ
Am J Sports Med; 2011 Nov; 39(11):2362-70. PubMed ID: 21856929
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of cartilage degradation and suppression of PGE
Akhtar N; Khan NM; Ashruf OS; Haqqi TM
Nutrition; 2017 Jan; 33():1-13. PubMed ID: 27908544
[TBL] [Abstract][Full Text] [Related]
38. Identification of opticin, a member of the small leucine-rich repeat proteoglycan family, in human articular tissues: a novel target for MMP-13 in osteoarthritis.
Monfort J; Tardif G; Roughley P; Reboul P; Boileau C; Bishop PN; Pelletier JP; Martel-Pelletier J
Osteoarthritis Cartilage; 2008 Jul; 16(7):749-55. PubMed ID: 18164633
[TBL] [Abstract][Full Text] [Related]
39. Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro.
Bau B; Gebhard PM; Haag J; Knorr T; Bartnik E; Aigner T
Arthritis Rheum; 2002 Oct; 46(10):2648-57. PubMed ID: 12384923
[TBL] [Abstract][Full Text] [Related]
40. Effects of FGF-2 and FGF receptor antagonists on MMP enzymes, aggrecan, and type II collagen in primary human OA chondrocytes.
Nummenmaa E; Hämäläinen M; Moilanen T; Vuolteenaho K; Moilanen E
Scand J Rheumatol; 2015; 44(4):321-30. PubMed ID: 25743336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
